Navigation Links
Volcano Reports 18 Percent Increase in Total Third Quarter Revenues
Date:10/31/2011

to those factors, on purchasing decisions with respect to the company's products, the pace and extent of market adoption of the company's products and technologies, the inherent uncertainty in the process of obtaining regulatory approval or clearance for Volcano's products or devices, the success of Volcano's   growth strategies, risks associated with Volcano's international operations, the impact of the recent events in Japan, timing and achievement of product development milestones, outcome of ongoing litigation, the impact and benefits of market development, dependence upon third parties, product introductions, unexpected new data, safety and technical issues, market conditions and other risks inherent to medical and/or telecom device development and commercialization. These and additional risks and uncertainties are more fully described in Volcano's filings made with the Securities and Exchange Commission, including our recent annual report on Form 10-K for the year ended December 31, 2010, and other filings made with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Volcano disclaims any obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.VOLCANO CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) (Unaudited) September 30, December 31,20112010 Assets Current assets: Cash and cash equivalents

$
53,091$
43,429 Short-term available-for-sale investments  

154,314175,283 Accounts receivable, net

63,41359,133 Inventories

46,46340,499 Prepaid expenses and other current assets

8,6736,643 Total current assets

325,954324,987 Long-term available-for-sale investments

33,92826,804 Property and equipment, net

73,41156,503 Intangible assets, ne
'/>"/>

SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
2. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
3. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
4. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
5. Volcano Corporation Announces Litigation Status
6. Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast
7. Volcano Corporation Announces Preliminary Record Revenues for Fourth Quarter 2009; Total Year Revenues are Expected to Exceed Prior Guidance
8. Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
9. Volcano Announces Installed Base Growth Milestone
10. Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging
11. Volcano Corporation Completes Acquisition of Lumen Biomedicals Xtract(TM) Thrombus Aspiration Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015  Lyric Pharmaceuticals Inc. today announced ... totaling $20.4 million. The financing, co-led by RiverVest Venture ... by Aperture Venture Partners. Lyric is ... David Wurtman , M.D., M.B.A., President & Chief Executive ... Medical Officer.  In 2014, Lyric closed a seed financing ...
(Date:2/26/2015)... Feb. 26, 2015 Columbia Laboratories, Inc. ... Company"), a specialty pharmaceutical company focused on the ... initiate a Phase II clinical trial for COL-1077, ... transvaginal pipelle-directed endometrial biopsy in the second quarter ... ("IND") submission feedback from the United States Food ...
(Date:2/26/2015)...  Great Basin Scientific, Inc. ("Great Basin") announced today ... of up to 2,724,000 units at $8.80 per Unit.  ... preferred stock and eight Series C warrants.  Each share ... four shares of common stock and each Series C ... stock at an exercise price of $2.55 per share.  ...
Breaking Medicine Technology:Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 2Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 3Great Basin Scientific, Inc. Announces Commencement of Public Offering 2Great Basin Scientific, Inc. Announces Commencement of Public Offering 3
(Date:2/26/2015)... (PRWEB) February 26, 2015 SpendWell ... celebrated its launch to its first customer today, ... and their covered dependents. , SpendWell delivers ... care services, combining real-time price transparency with e-commerce. ... variety of routine health care services and allows ...
(Date:2/26/2015)... 26, 2015 In a nested-case control study ... world with a relatively low incidence of liver cancer, statin ... according to a new study published February 26 ... , Previous studies have reported this association but most used ... cancer incidence rate, such as Asia. Katherine A. McGlynn, Ph.D., ...
(Date:2/26/2015)... February 26, 2015 The Reproductive Science ... their newly renovated office in Lawrenceville, NJ. ... Center of New Jersey’s physicians, and NJ Top Docs, ... care in the areas of infertility and reproductive medicine. ... excellent success rates and providing current, high quality medical ...
(Date:2/26/2015)... Austin, Texas (PRWEB) February 26, 2015 The ... only enabled local pastor and Central Texas resident John Short ... so much, he has set out to climb Mt. Kilimanjaro, ... to help stop human trafficking. , Starting in his late ... worsened and eventually his hip bones and sockets were bone ...
(Date:2/26/2015)... 2015 Eating disorders are serious, ... adulthood. In response to emerging research regarding eating ... of National Eating Disorders Awareness Week, the Society ... evidence-based recommendations for the medical management of restrictive ... a new approach to assessing the degree of ...
Breaking Medicine News(10 mins):Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 2Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 3Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 2Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 3
... May 13 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE ... scheduled a conference call to discuss the first quarter ... general business update on Monday, May 18, 2009 at ... please dial (800) 357-0498, for international callers dial (850) ...
... help educate people about the importance of working ... Store, America,s leading provider of power wheelchairs and ... May 4-8. The company joined professional compliance organizations ... ongoing efforts to reinforce their commitments to integrity ...
... First Boston Pharma announces the acquisition of ... of solid dose and soft chew pharmaceuticals and supplements. ... Pharma, LLC. Leading the First Boston Pharma organization ... one of the industry,s foremost innovators in over-the-counter ("OTC") ...
... Holdings, Inc. (NYSE: ZMH ; SWX: ZMH) announced ... Annual Health Care Conference in Boston, Massachusetts, on May 19, ... presentation can be accessed via Zimmer,s Investor Relations website at ... will be archived for replay following the conference. About the ...
... Sales Will Command 54 percent of the Market by ... WALTHAM, Mass., May 13 Decision Resources, one of ... pharmaceutical and healthcare issues, finds that the non-small-cell lung ... 2013, growing from $27.7 million in 2008 to $52.1 ...
... SHENZHEN, China, May 13 /PRNewswire-Asia/ -- Winner Medical Group Inc.,(OTC ... financial results for the second quarter ended March 31,2009. The ... with,the United States Securities and Exchange Commission. , , ... Total net sales revenue increased by 15.31% over the second ...
Cached Medicine News:Health News:ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2009 and to Provide a Business Update 2Health News:The SCOOTER Store Recognizes National Corporate Compliance & Ethics Week 2Health News:First Boston Pharma, LLC Acquires NutraMax Products, Inc. 2Health News:India's Non-Small-Cell Lung Cancer Drug Market Will Almost Double by 2013 2Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 2Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 3Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 4Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 5Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 6Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 7Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 8Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 9Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 10Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 11
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: